Recipharm grants International Environmental Award for research on the impact of chemical contaminants on environment and health
Erik Haeffler, VP Manufacturing Services and Head of CSR at Recipharm and Professor Alistair Boxall
Global CDMO Recipharm has presented t its 2016 International Environmental Award to Alistair Boxall, Professor in environmental science at the University of York, for his research into the impact of chemical contaminants on the environment and human health.
Spanning more than two decades, Professor Alistair Boxall’s research has led to an improved understanding of the emerging ecological and health risks posed by chemical contaminants, including pharmaceuticals and nanoparticles, in the natural environment.
In addition to his position at the University of York, he currently also serves as an academic coordinator of the Intelligent Assessment of Pharmaceuticals in the Environment (iPiE) project within the Innovative Medicines Initiative, and is also coordinator of the CAPACITIE project, which is currently exploring methods for monitoring pollution in cities.
This research has been integral to building commitment towards environmental matters.
Lars Backsell, Chair of the Board of Recipharm, said: “Alistair Boxall's work extends far beyond measuring concentration levels. It has helped change attitudes and improve understanding of the detection, fate, effect and risks of contaminants on both human health and whole ecosystems.”
“His research has been integral to building commitment towards environmental matters and is providing valuable guidance for future actions to decrease or avoid the negative effects of chemical contamination.”
Boxall said: “It is a great testament to today’s research programmes that the pharmaceutical industry is recognising the importance of environmental impact and actively adapting practices to reduce the effects of contaminants and safeguard the environment.”